Review of the Perioperative Management of Antithrombotic Therapy: 2022 CHEST Guidelines
The American College of Chest Physicians released a clinical practice executive summary on the perioperative management of antithrombotic therapy in August 2022. This session will review the summary, including 43 recommendations that have been changed from the 2012 iteration of the guidelines. The presentation will get providers up-to-date so that their workplace practices are based off the most recent evidence-based updates.
Learning Objectives
At the completion of this activity, the participant should be able to:
- Describe the mechanism of action, monitoring, and side effects of all current antithrombotic medications addressed in the CHEST guidelines
- Classify risk of peri-procedural thromboembolism/procedural bleeding for patients based on specific characteristics
- Discuss guideline recommended options for the timing of interruption/resumption for each anticoagulant
Presenter
Clara Forbes, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center. She received her PharmD from the University of Rhode Island in 2022. Her professional interests include emergency medicine and pediatrics.
Course Fee: Free for MCPHS alumni, full-time staff, and for all other professionals.
Release Date: June 13, 2023
Expiration Date: June 13, 2024
ACPE UAN: 0026-0000-23-015-H01-P | Knowledge
ACPE Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1.0 (0.1 CEU)
After registering or logging into mcphsce.org, you can view CE modules in our library.
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1.0 contact hours (0.1 CEUs).
To receive credit, participants must complete pre and post-assessments, view the entire presentation, and evaluate the session. Participant credit will be reported to the CPE Monitor upon conclusion. Transcripts may be printed from the CPE Monitor.
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.
Clara Forbes, PharmD, has no relevant financial relationships with ineligible companies to disclose.
Content Reviewer, Barbara Damas, PharmD, BCPS, has no relevant financial relationships with ineligible companies to disclose.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
No funding from industry provided for this event. No exhibitors will be present.